Cerexa

Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and life–threatening infections. Cerexa was sold to Forest Laboratories in January 2007 in the largest private biotech M&A in history.


Partner

Brent Ahrens

Investment

Series A